Exchange Traded Concepts’s Arcus Biosciences RCUS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-13,922
| Closed | -$109K | – | 1469 |
|
|
2025
Q1 | $109K | Buy |
13,922
+4,013
| +40% | +$31.5K | ﹤0.01% | 1121 |
|
|
2024
Q4 | $148K | Hold |
9,909
| – | – | ﹤0.01% | 1055 |
|
|
2024
Q3 | $152K | Sell |
9,909
-1,954
| -16% | -$29.9K | ﹤0.01% | 1060 |
|
|
2024
Q2 | $181K | Sell |
11,863
-3,690
| -24% | -$56.2K | ﹤0.01% | 885 |
|
|
2024
Q1 | $294K | Buy |
15,553
+8,737
| +128% | +$165K | 0.01% | 802 |
|
|
2023
Q4 | $130K | Buy |
6,816
+1,729
| +34% | +$33K | ﹤0.01% | 853 |
|
|
2023
Q3 | $91.3K | Sell |
5,087
-1,888
| -27% | -$33.9K | ﹤0.01% | 932 |
|
|
2023
Q2 | $142K | Buy |
+6,975
| New | +$142K | ﹤0.01% | 858 |
|
|
2023
Q1 | – | Sell |
-28,445
| Closed | -$588K | – | 1255 |
|
|
2022
Q4 | $588K | Buy |
28,445
+948
| +3% | +$19.6K | 0.02% | 475 |
|
|
2022
Q3 | $719K | Buy |
+27,497
| New | +$719K | 0.02% | 315 |
|